Surgical salvage of recurrence after resection of colorectal liver metastases: Incidence and outcomes Journal Article

   


Authors: Rahbari, N. N.; D'Angelica, M. I.
Article Title: Surgical salvage of recurrence after resection of colorectal liver metastases: Incidence and outcomes
Abstract: Surgical resection remains the primary curative treatment option for patients with colorectal liver metastases. While the majority of patients will develop tumor relapse within or outside of the liver after hepatic metastasectomy, a subset of these patients may be amenable to salvage surgical resection. However, outcomes for this approach are not well defined. In this article, we summarize the current evidence for the incidence, feasibility and outcomes of salvage resection for recurrence after initial resection of colorectal liver metastases.
Keywords: survival; bevacizumab; surgery; metastases; contrast-enhanced ct; 1st-line treatment; hepatic; randomized phase-iii; benefit; repeat hepatectomy; multiinstitutional analysis; cancer
Journal Title: Hepatic Oncology
Volume: 4
Issue: 1
ISSN: 2045-0923
Publisher: Future Medicine  
Date Published: 2017-01-01
Start Page: 25
End Page: 33
Language: English
ACCESSION: WOS:000406848900005
DOI: 10.2217/hep-2017-0002
PROVIDER: wos
PUBMED: 28768424
PMCID: PMC6095401
Notes: Review -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael D'Angelica
    777 D'Angelica
  2. Nuh Nabi Rahbari
    2 Rahbari
Related MSK Work